breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Marginal read alignment evidence (highest frequency 20 of 48 shown, sorted by frequency from high to low) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
* | NZ_CP009273 | 816,005 | 0 | G | T | 61.5% | 4.9 / 16.9 | 13 | L222L (CTG→CTT) | ybhL | Bax inhibitor‑1/YccA family protein |
* | NZ_CP009273 | 497,020 | 0 | A | C | 60.9% | 13.2 / 26.9 | 24 | *559E (TAA→GAA) | ybaL | Kef family K(+) transporter |
* | NZ_CP009273 | 497,031 | 0 | A | C | 58.3% | 2.2 / 21.8 | 24 | V555G (GTG→GGG) | ybaL | Kef family K(+) transporter |
* | NZ_CP009273 | 353,591 | 0 | T | C | 57.1% | 4.9 / 14.4 | 14 | K271E (AAA→GAA) | cynR | transcriptional regulator CynR |
* | NZ_CP009273 | 3,852,866 | 0 | A | C | 57.1% | 5.1 / 17.2 | 14 | V204G (GTG→GGG) | yidK | solute:sodium symporter family transporter |
* | NZ_CP009273 | 990,891 | 0 | T | C | 52.9% | ‑5.3 / 22.3 | 17 | E185G (GAG→GGG) | ssuD | FMNH2‑dependent alkanesulfonate monooxygenase |
* | NZ_CP009273 | 4,061,105 | 0 | A | G | 52.2% | 10.0 / 27.4 | 23 | L511P (CTG→CCG) | yihQ | sulfoquinovosidase |
* | NZ_CP009273 | 497,013 | 0 | A | C | 52.0% | 18.2 / 30.7 | 25 | intergenic (+128/+5) | gsk/ybaL | inosine/guanosine kinase/Kef family K(+) transporter |
* | NZ_CP009273 | 2,380,341 | 0 | G | A | 52.0% | 8.3 / 35.5 | 25 | intergenic (+31/‑72) | yfbL/yfbM | M28 family metallopeptidase/YfbM family protein |
* | NZ_CP009273 | 3,436,636 | 0 | A | C | 51.8% | 37.9 / 46.8 | 27 | V274G (GTA→GGA) | secY | preprotein translocase subunit SecY |
* | NZ_CP009273 | 645,920 | 0 | A | T | 50.0% | 12.1 / 11.4 | 23 | R9R (CGT→CGA) | citE | citrate (pro‑3S)‑lyase subunit beta |
* | NZ_CP009273 | 3,392,363 | 0 | T | C | 50.0% | 2.7 / 36.1 | 28 | Q325Q (CAA→CAG) | mreC | rod shape‑determining protein MreC |
* | NZ_CP009273 | 3,199,794 | 0 | C | T | 48.0% | 15.1 / 15.3 | 25 | intergenic (‑179/‑28) | ttdR/ttdA | DNA‑binding transcriptional activator TtdR/L(+)‑tartrate dehydratase subunit alpha |
* | NZ_CP009273 | 5,159 | 0 | G | A | 45.5% | 11.6 / 10.2 | 22 | intergenic (+139/‑75) | thrC/yaaX | threonine synthase/DUF2502 domain‑containing protein |
* | NZ_CP009273 | 5,162 | 0 | T | A | 45.5% | 19.9 / 10.0 | 23 | intergenic (+142/‑72) | thrC/yaaX | threonine synthase/DUF2502 domain‑containing protein |
* | NZ_CP009273 | 3,806,632 | 0 | C | T | 44.8% | 16.5 / 13.1 | 29 | S181L (TCG→TTG) | coaBC | bifunctional phosphopantothenoylcysteine decarboxylase/phosphopantothenate‑‑cysteine ligase CoaBC |
* | NZ_CP009273 | 3,284,171 | 0 | A | G | 42.9% | 23.7 / 49.0 | 43 | T667A (ACG→GCG) | yraJ | fimbrial biogenesis outer membrane usher protein |
* | NZ_CP009273 | 294,671 | 0 | A | C | 42.3% | 35.6 / 10.6 | 26 | Y659D (TAT→GAT) | paoC | aldehyde oxidoreductase molybdenum‑binding subunit PaoC |
* | NZ_CP009273 | 1,016,669 | 0 | T | A | 41.4% | 17.9 / 38.3 | 29 | S26T (TCA→ACA) | sxy | CRP‑S regulon transcriptional coactivator Sxy |
* | NZ_CP009273 | 2,148,082 | 0 | A | G | 41.2% | 19.8 / 38.9 | 34 | S196G (AGC→GGC) | mdtA | multidrug efflux RND transporter subunit MdtA |
Marginal new junction evidence (sorted from low to high skew) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | NZ_CP009273 | 3509341 = | 31 (0.970) | 4 (0.140) | 4/222 | 2.7 | 12.6% | intergenic (‑69/+38) | dam/damX | adenine‑specific DNA‑methyltransferase/cell division protein DamX |
? | NZ_CP009273 | 3509369 = | 27 (0.920) | intergenic (‑97/+10) | dam/damX | adenine‑specific DNA‑methyltransferase/cell division protein DamX | |||||
* | ? | NZ_CP009273 | = 3614246 | NA (NA) | 3 (0.100) | 3/216 | 3.0 | NA | coding (1695/4236 nt) | rhsB | rhs element protein RhsB |
? | NZ_CP009273 | = 3614234 | NA (NA) | coding (1683/4236 nt) | rhsB | rhs element protein RhsB |